Delivery Order SPE2DB20D9214-SPE2DB24FD4TK

Award Date 4/25/24

Potential Completion Date 4/26/24

Potential Value $4.2K

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $4,169.59 firm fixed-price delivery order is for the supply of the prescription drug Xtandi (40 mg tablets) to support the medical needs of military personnel and their dependents at Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA through December 31, 2025, which enables the agency to issue delivery orders for a wide range of pharmaceutical products. This contract award does not have a set-aside designation.

Generated 7/25/24, 10:18 AM